BioAge Labs (BIOA) Change in Accured Expenses (2023 - 2026)
BioAge Labs (BIOA) posted Change in Accured Expenses of -$3.8 million for Q1 2026, down 383.83% sequentially from $1.4 million in Q4 2025, and up 44.7% YoY from -$2.7 million in Q1 2025.
BioAge Labs (BIOA) Change in Accured Expenses (2023 - 2026) Analysis & Trends
BioAge Labs has reported Change in Accured Expenses for 4 years, with the latest figure at -$3.8 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 44.7% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$306000.0 (down 116.97% YoY) and the FY2025 annual result came in at -$3.4 million, down 173.73% from the prior year.
- Change in Accured Expenses eased to -$3.8 million in Q1 2026 per BIOA's latest filing, from $1.4 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $8.2 million in Q3 2024 and troughed at -$6.9 million in Q1 2025.
- A 4-year average of $38200.0 and a median of $406000.0 in 2025 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 264.55% in 2025, down 106.61% in 2025.
- Over 4 years, Change in Accured Expenses stood at $3.0 million in 2023, then dropped by 26.59% to $2.2 million in 2024, then tumbled by 38.71% to $1.4 million in 2025, then slumped by 383.83% to -$3.8 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$3.8 million, $1.4 million, and -$542000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.86 Mn |
| Jun 30, 2026 | 3.86 Mn |
| Mar 31, 2026 | -3.84 Mn |
| Mar 31, 2026 | -3.84 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -542,000.00 |
| Sep 30, 2025 | -542,000.00 |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | -6.95 Mn |
| Mar 31, 2025 | -6.95 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | -1.66 Mn |
| Mar 31, 2024 | -4.12 Mn |
| Mar 31, 2024 | -4.12 Mn |